Baclofen
Rank #275 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$44.2M
Total Cost
1,916,226
Total Claims
$44.2M
Total Cost
46,966
Prescribers
$23
Cost per Claim
403,533
Beneficiaries
2,526,672
30-Day Fills
$941
Avg Cost/Provider
41
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$44.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $44.2M total
Top Prescribers of Baclofen
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Paul Garell | Neurosurgery | Carmel, NY | 85 | $106K |
| 2 | Caroline Mcwilliams | Internal Medicine | Newtown Square, PA | 885 | $57K |
| 3 | Nicholas Zendler | Neurology | Garden City, MI | 15 | $56K |
| 4 | Rene Pulido | Family Practice | Jacksonville, FL | 2,693 | $51K |
| 5 | Andrew Graf | Internal Medicine | Plymouth Meeting, PA | 1,148 | $34K |
| 6 | Patrick O'brien | Physical Medicine and Rehabilitation | Raleigh, NC | 1,391 | $33K |
| 7 | Xiandong Shi | Internal Medicine | Flushing, NY | 1,097 | $31K |
| 8 | Paul Catanzaro | Interventional Pain Management | Saint Louis, MO | 2,656 | $31K |
| 9 | Roberto Alvarez | Rheumatology | Aibonito, PR | 2,237 | $30K |
| 10 | Srinath Tadakamalla | Family Practice | Harrisonville, MO | 852 | $28K |
| 11 | Daniel Miller | Internal Medicine | Columbus, OH | 721 | $28K |
| 12 | Babak Zamiri | Rheumatology | Riverside, CA | 910 | $28K |
| 13 | Gregory Park | Physical Medicine and Rehabilitation | West Springfield, MA | 218 | $28K |
| 14 | Casilda Balmaceda | Neurology | New York, NY | 1,949 | $28K |
| 15 | Mohamed Tarakji | Neurology | Flint, MI | 1,767 | $27K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 272 | Bosutinib (Bosulif) | $44.9M | 2,962 |
| 273 | Tramadol Hcl (Tramadol Hcl) | $44.9M | 5,226,406 |
| 274 | Finasteride (Finasteride) | $44.6M | 2,766,115 |
| 275 | Baclofen (Baclofen) | $44.2M | 1,916,226 |
| 276 | Fluoxetine Hcl (Fluoxetine Hcl) | $43.9M | 2,891,768 |
| 277 | Patiromer Calcium Sorbitex (Veltassa) | $43.4M | 40,534 |
| 278 | Hydralazine Hcl (Hydralazine Hcl) | $43.2M | 2,256,779 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology